Radiosensitization of human glioma cells by tamoxifen is associated with the inhibition of PKC-ι activity in vitro

Oncology Letters
Lei YangFenju Liu


The present study aimed to investigate the radiosensitizing effects of tamoxifen (TAM), a non-steroidal anti-estrogen drug, in human glioma A172 and U251 cells in vitro. A colony-forming assay revealed that TAM enhances radiosensitivity in A172 and U251 cells. Treatment with TAM also increased the percentage of apoptotic cells subsequent to ionizing radiation, and increased the expression of apoptotic markers, including cleaved caspase-3 and poly(ADP-ribose) polymerase. Ionizing radiation induced G2/M phase arrest, which was alleviated within 24 h when the radiation-induced DNA damage was repaired. However, flow cytometry analysis revealed that TAM treatment delayed the recovery of cell cycle progression. Additional examination demonstrated that TAM-mediated protein kinase C-ι (PKC-ι) inhibition may lead to the activation of pro-apoptotic B-cell lymphoma 2-associated death promoter, and the dephosphorylation of cyclin-dependent kinase 7, resulting in increased cell apoptosis and sustained G2/M phase arrest following exposure to radiation. The present data indicate that the radiosensitizing effects of TAM on glioma cells are partly due to the inhibition of PKC-ι activity in vitro.


Oct 1, 1992·Neurosurgery·W ZhangY Nozawa
Apr 15, 1988·Biochemical Pharmacology·T NakadateP M Blumberg
Mar 1, 1982·Acta Pharmacologica Et Toxicologica·N WilkingN O Theve
Aug 1, 1995·The Journal of Urology·Y S PuM K Lai
Mar 6, 1996·Journal of the National Cancer Institute·Y KangR R Perry
Jun 7, 1996·The Journal of Biological Chemistry·U GundimedaR Gopalakrishna
Mar 6, 1999·Journal of Neurosurgery·A M DonsonN K Foreman
Oct 12, 2001·Apoptosis : an International Journal on Programmed Cell Death·S Mandlekar, A N Kong
Sep 21, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Normand LaperriereCancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group
Feb 8, 2005·Tissue & Cell·Elona BicakuMildred E Acevedo-Duncan
Mar 11, 2005·The New England Journal of Medicine·Roger StuppNational Cancer Institute of Canada Clinical Trials Group
Jul 5, 2005·The Journal of Biological Chemistry·Roderick P RegalaAlan P Fields
Dec 22, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Ciro ParlatoAldo Moraci
Jan 24, 2008·Cell Proliferation·Rekha S PatelMildred E Acevedo-Duncan
Jan 24, 2008·Oncogene·R M BaldwinI A J Lorimer
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Apr 2, 2011·Cell Cycle·Jinpeng HeGuangming Zhou
Jun 1, 2013·Cancer Research·Latika KohliKevin A Roth
Sep 17, 2013·Cell Cycle·Miriam Merzel Schachter, Robert P Fisher


Mar 3, 2018·International Journal of Molecular Sciences·Chao RongJochen Hess
May 5, 2018·Cancer Investigation·Tatiana Anatolievna BogushAndrey Borisovich Ryabov
Sep 16, 2020·Seminars in Cancer Biology·Diego Gómez-CoronadoMaría E Fernández-Suárez

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.